Skip to content

New fixed-dose combination pills measure up to Atripla - corrected version*

Are antiretroviral switch or simplification studies of benefit for patients?

The research agenda for antiretroviral prevention – now it gets complex

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

Where is HIV vaccine research heading?

Global HIV Vaccine Enterprise director, Dr Alan Bernstein

Imiquimod a good treatment for pre-cancerous anal lesions in men with HIV

Tenofovir microbicide halves genital herpes infections and appears safe

Salim Abdool Karim, Clinical Infectious Diseases Epidemiologist. ©IAS/Marcus Rose/Workers' Photos

Microbicides can work, CAPRISA trial shows, but more trials needed before approval

Prof. Quarraisha Abdool Karim, Associate Scientific Director of CAPRISA. ©IAS/Marcus Rose/Workers' Photos

Maraviroc potentially useful if neurological disease is present